24.03
Schlusskurs vom Vortag:
$23.95
Offen:
$23.95
24-Stunden-Volumen:
681.66K
Relative Volume:
1.41
Marktkapitalisierung:
$1.17B
Einnahmen:
$96.21M
Nettoeinkommen (Verlust:
$-12.13M
KGV:
-76.77
EPS:
-0.313
Netto-Cashflow:
$10.64M
1W Leistung:
+4.42%
1M Leistung:
+12.57%
6M Leistung:
-9.79%
1J Leistung:
+10.50%
Biolife Solutions Inc Stock (BLFS) Company Profile
Firmenname
Biolife Solutions Inc
Sektor
Telefon
(425) 401-1400
Adresse
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BLFS
Biolife Solutions Inc
|
24.04 | 1.17B | 96.21M | -12.13M | 10.64M | -0.313 |
|
ISRG
Intuitive Surgical Inc
|
436.65 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
147.75 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.69 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
36.16 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
208.10 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2024-09-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-04-25 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-05-14 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Eingeleitet | Cowen | Outperform |
| 2020-08-11 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Bestätigt | Maxim Group | Buy |
| 2020-02-24 | Eingeleitet | Lake Street | Buy |
| 2020-02-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Fortgesetzt | B. Riley FBR | Buy |
| 2020-01-08 | Eingeleitet | Stephens | Overweight |
| 2019-11-21 | Eingeleitet | Oppenheimer | Outperform |
| 2019-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-11-10 | Bestätigt | Maxim Group | Buy |
| 2017-09-19 | Bestätigt | Maxim Group | Buy |
| 2017-07-05 | Hochstufung | Janney | Neutral → Buy |
| 2017-03-10 | Bestätigt | Maxim Group | Buy |
| 2017-01-19 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Biolife Solutions Inc Aktie (BLFS) Neueste Nachrichten
Casdin discloses 9.7% BioLife Solutions stake (NASDAQ: BLFS) - Stock Titan
BioLife Solutions Inc (BLFS) Shares Surge 3.0% -- What GF Score of 73 Tells Investors - GuruFocus
BioLife Solutions(BLFS.US) 10% Shareholder Sells US$28.13 Million in Common Stock - Moomoo
[Form 4] BIOLIFE SOLUTIONS INC Insider Trading Activity - Stock Titan
Casdin Partners (NASDAQ: BLFS) files Form 144 for 650,000-share resale notice - Stock Titan
Summit Creek Advisors LLC Grows Stock Holdings in BioLife Solutions, Inc. $BLFS - MarketBeat
Why BioLife Solutions (BLFS) Is Up 13.4% After Q1 Return To Profitability And Reaffirmed Outlook - simplywall.st
BLFS (NASDAQ) affiliate notifies sale of 250,000 shares via BMO Capital Markets - Stock Titan
BLFS Stock Price, Quote & Chart | BIOLIFE SOLUTIONS INC (NASDAQ:BLFS) - ChartMill
BioLife (NASDAQ: BLFS) proposed sale of 300,000 shares, $6.69M listed - Stock Titan
Wall Street analysts think BioLife Solutions (BLFS) could surge 70.78%: Read this before placing a bet - MSN
Number of shareholders of BioLife Solutions, Inc. – NASDAQ:BLFS - TradingView
Number of shareholders of BioLife Solutions, Inc. – DUS:BJX1 - TradingView
T. Rowe Price (BLFS) reports 6.51M shares, 13.5% stake disclosed - Stock Titan
BLFS: BioLife SolutionsInteractive Chart - Zacks Investment Research
How Biolife Solutions Inc. (BLFS) Affects Rotational Strategy Timing - Stock Traders Daily
A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term Momentum - Yahoo Finance
Lake Street Sticks to Their Buy Rating for BioLife Solutions (BLFS) - The Globe and Mail
BioLife Solutions, Inc. (BLFS) tops Q1 earnings and revenue estimates - MSN
BioLife Solutions (BLFS) Q4 Profit Challenges Ongoing Loss Narrative - Sahm
BioLife Solutions (NASDAQ:BLFS) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
BioLife Solutions Earnings Call Highlights Growth Path - TipRanks
BioLife Solutions, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
BioLife Solutions Q1 2026 Earnings Call Transcript - MarketBeat
Earnings call transcript: BioLife Solutions Q1 2026: Revenue Surges, Stock Rises - Investing.com
Earnings call transcript: BioLife Solutions Q1 2026: Revenue Surges, Stock Rises By Investing.com - Investing.com South Africa
BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
BioLife Solutions Inc (NASDAQ:BLFS) Q1 2026 Earnings Beat Signals Profitability Milestone - ChartMill
BioLife Solutions Q1 Earnings Call Highlights - Yahoo Finance
BioLife Solutions reports Q1 2026 revenue $27.5M, adjusted EBITDA $6.2M, GAAP net income $1.2M - TradingView
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q1 Revenue $27.5M, vs. FactSet Est of $25.7M - marketscreener.com
Q1 2026 growth lifts BioLife Solutions (NASDAQ: BLFS) back to profit - Stock Titan
BioLife Solutions (NASDAQ: BLFS) grows Q1 2026 revenue 25% - Stock Titan
Biolife Solutions, Inc. Reiterates Earnings Guidance for 2026 - marketscreener.com
BioLife Solutions earnings up next as profitability test looms By Investing.com - Investing.com South Africa
BioLife Solutions earnings up next as profitability test looms - Investing.com India
Invesco reports 2.35M BioLife shares (NASDAQ: BLFS) holding 4.9% - Stock Titan
MSN Money - MSN
BioLife Solutions (BLFS) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
BioLife Solutions 2025 Executive Compensation, Company Objectives, and Pay-for-Performance Practices Detailed - Minichart
Executive pay, bonuses and board structure at BioLife Solutions (NASDAQ: BLFS) - Stock Titan
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway - Zacks Investment Research
Finanzdaten der Biolife Solutions Inc-Aktie (BLFS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Biolife Solutions Inc-Aktie (BLFS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L | 10% Owner |
May 19 '26 |
Sale |
22.65 |
300,000 |
6,795,000 |
5,657,165 |
| Casdin Partners Master Fund, L | 10% Owner |
May 20 '26 |
Sale |
23.70 |
250,000 |
5,925,000 |
5,407,165 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):